These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8052594)

  • 1. [Fatal diffuse alveolar damage after gold medication].
    Mack U; Schmidt K; Heine M
    Pneumologie; 1994 May; 48(5):405-8. PubMed ID: 8052594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fatal pulmonary fibrosis caused by gold therapy?].
    Chatzigiannis I; Schmidt KL; Stambolis C
    Z Rheumatol; 1984; 43(2):49-58. PubMed ID: 6428074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
    Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R
    Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse pulmonary injury associated with gold treatment.
    Winterbauer RH; Wilske KR; Wheelis RF
    N Engl J Med; 1976 Apr; 294(17):919-21. PubMed ID: 130554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report and literature analysis of the clinical factors relating to the development of fibrotic changes in gold lung].
    Aoshiba K; Fukuda I; Mochizuki M; Tamaoki J; Konno K; Takizawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):336-43. PubMed ID: 2113147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung disease associated with gold therapy.
    Goldman MP; Rockwood RP
    Clin Pharm; 1986 Jun; 5(6):467-8. PubMed ID: 3087683
    [No Abstract]   [Full Text] [Related]  

  • 8. Enterocolitis complicating chrysotherapy. Case report and review of the literature.
    Sukenik S; Hirsch M; Yanai-Inbar I; Krawiec J; Freund B; Horowitz Y
    Isr J Med Sci; 1982 Oct; 18(10):1040-3. PubMed ID: 6816751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar macrophage gold retention in rheumatoid arthritis.
    Garcia JG; Munim A; Nugent KM; Bishop M; Hoie-Garcia P; Parhami N; Keogh BA
    J Rheumatol; 1987 Jun; 14(3):435-8. PubMed ID: 3114483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome.
    Kang D; Nakayama T; Togashi M; Yamamoto M; Takahashi M; Kunugi S; Ishizaki M; Fukuda Y
    Hum Pathol; 2009 Nov; 40(11):1618-27. PubMed ID: 19647854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcerative colitis caused by oral gold therapy in rheumatoid arthritis].
    Bross-Bach U; Saal JG; Hartmann F; Müller CA; Waller HD
    Z Rheumatol; 1987; 46(4):201-4. PubMed ID: 3118590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental production of diffuse pulmonary fibrosis and alveolitis in cattle: the effects of repeated dosage with 3, methyl indole.
    Logan A; Selman IE; Wiseman A; Allan EM; Pirie HM
    Res Vet Sci; 1983 Jan; 34(1):97-108. PubMed ID: 6836186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary gold toxicity.
    Morley TF; Komansky HJ; Adelizzi RA; Giudice JC
    Eur J Respir Dis; 1984 Nov; 65(8):627-32. PubMed ID: 6440806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis with diffuse pulmonary rheumatoid nodules.
    Kitamura A; Matsuno T; Narita M; Shimokata K; Yamashita Y; Mori N
    Pathol Int; 2004 Oct; 54(10):798-802. PubMed ID: 15482571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonexudative diarrhea after gold salt therapy: case report and review of the literature.
    Nagler J; Paget SA
    Am J Gastroenterol; 1983 Jan; 78(1):12-4. PubMed ID: 6401389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
    Sugiyama K; Kawai T
    Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold-induced lung disease.
    Heyd J; Simmeran A
    Postgrad Med J; 1983 Jun; 59(692):368-70. PubMed ID: 6415637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.
    Churg A; Müller NL; Silva CI; Wright JL
    Am J Surg Pathol; 2007 Feb; 31(2):277-84. PubMed ID: 17255773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary side effects of gold treatment].
    Reinicke C
    Z Gesamte Inn Med; 1981 Dec; 36(24):969-72. PubMed ID: 7336798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.